From: Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer
Clinicopathological features | Case | Percent (%) |
---|---|---|
Age (years) | ||
 ≤50 | 40 | 66.7 |
 >50 | 20 | 33.3 |
Gender | ||
 Male | 45 | 75.0 |
 Female | 15 | 25.0 |
Growth pattern | ||
 Papillary | 40 | 66.7 |
 Non-papillary | 20 | 33.3 |
Pathological stage | ||
 pTa | 28 | 46.7 |
 pT1 | 15 | 25.0 |
 pT2 | 10 | 16.7 |
 pT3 | 5 | 8.3 |
 pT4 | 2 | 3.3 |
Tumor grade | ||
 G1 | 15 | 25.0 |
 G2 | 35 | 58.3 |
 G3 | 10 | 16.7 |
Lymph node metastasis | ||
 Negative | 40 | 66.7 |
 Positive | 20 | 33.3 |